P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL

Journal article

Open access

Peer reviewed

P. Strati, M. Coleman, D. Stevens, S. Ma, C. Patti, M. Levy, I. S. Lossos, P. Ramakrishnan Geethakumari, S. Lam, R. Calvo, …

HemaSphere, Vol.6(Suppl), pp.1019-1020

2022-06-23

Abstract

Posters

url

https://doi.org/10.1097/01.hs9.0000847384.23751.21View

Published (Version of record) Open

10 Record Views

Title: P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL
Creators: P. Strati - The University of Texas MD Anderson Cancer Center
M. Coleman - Clinical Research Alliance/Weill Cornell Medicine, New York City, NY
D. Stevens - Norton Cancer Institute, Louisville, KY
S. Ma - Northwestern University
C. Patti - A.O.O.R. Villa Sofia-Cervello, U. O. Ematologia I, Palermo, Italy
M. Levy - Baylor University Medical Center
I. S. Lossos - Sylvester Comprehensive Cancer Center
P. Ramakrishnan Geethakumari - Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Cente, Dallas, TX, United States of America
S. Lam - London Health Sciences Centre
R. Calvo - AstraZeneca, Gaithersburg, MD
K. Higgins - AstraZeneca
L. Budde - City Of Hope National Medical Center
Publication Details: HemaSphere, Vol.6(Suppl), pp.1019-1020
Publisher: Lippincott Williams & Wilkins
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031758017402976